Omega-3 supplement tested in women with polycystic ovary syndrome
Tests an omega-3 supplement against a placebo in women with polycystic ovary syndrome.
Key facts
- Who runs it
- Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Where
- Dhaka, BangladeshSee the site
- Trial code
- Registry title
- Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.
- Status
- Enrolling by invitation
- People taking part
- 68 people, planned
- Started
- 22 Apr 2025
- Planned end
- 30 Dec 2025
- Type of study
- Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- Omega 3 fatty acids
- Omega -3 fatty acids
- Record updated
- 24 July 2025
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for women with newly diagnosed polycystic ovary syndrome (PCOS). Half of the women get Omega-3 and half get a placebo for 3 months.
- Age
- Above 18 years up to 35 years (the registry lists 18 to 36 years).
- Sex
- Women only.
- Disease stage
- Newly diagnosed PCOS, meeting the Rotterdam criteria.
- Earlier treatment
- Cannot have taken Omega-3 supplements in the last three months.
Main reasons for not taking part
- Pregnant or breastfeeding
- History of diabetes (except if meeting metabolic syndrome criteria)
- Any chronic illness such as liver, kidney or heart disease
- Any acute or chronic infection or inflammatory disease
- Known allergy to fish oil or Omega-3 supplements
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Age above 18 years up to 35 years
- Newly diagnosed case of PCOS
Who cannot take part
- Patients receiving Omega-3 supplementation within the last three months
- History of diabetes mellitus (except those meeting metabolic syndrome criteria)
- Any chronic illness (e.g. liver disease, kidney disease, cardiovascular disease)
- Any acute or chronic infective or inflammatory disease
- Exclusion of PCOS mimicking disease include hyperprolactinemia, adrenal hyperandrogenism, ovarian hyperandrogenism, cushing's syndrome, acromegaly etc
- Known allergy to fish oil or Omega-3 supplements
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 36 years old?
Where in Bangladesh
- Fariba kabirDhaka, BangladeshEnrolling by invitation
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if Omega-3 works to treat Polycystic ovary syndrome in women. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are:
Read full original descriptionShow less
Does Omega-3 lower the number of times participant to treat metabolic syndrome What medical problems do participants have when taking drug Omega-3.Researchers will compare drug Omega-3 to a placebo (a look-alike substance that contains no drug) to see if drug Omega-3 used to treat PCOS.
Participants will:
Take Omega-3 or a placebo every day for 3 months Visit the clinic once every 6 weeks for checkups and tests Keep a diary of their symptoms and menstrual history.
The 2 groups in the trial
- Omega-3Treatment being tested
Participants received Omega-3 1gm tablet orally twice daily for 12 weeks.
Treatment: Omega 3 fatty acids and Omega -3 fatty acids
- placeboPlacebo, for comparison
Participants received Omega-3 1gm placebo matching Omega-3 tablet orally twice daily for 12 weeks
Treatment: Omega 3 fatty acids and Omega -3 fatty acids
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Randomized Double-Blind, Placebo-Controlled Trial
- Plain-language title
- Omega-3 supplement tested in women with polycystic ovary syndromeGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT07036952, who can take part
- Record updated
- 24 July 2025